Results 11 to 20 of about 1,730,491 (239)
Extraintestinal Clostridioides difficile infection
IDCases, 2020 Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai +6 more
doaj +4 more sources
Clostridioides difficile Infection [PDF]
RGUHS Journal of Medical Sciences, 2022 In the past decade Clostrdioides difficile has become a leading enteric pathogen causing antibiotic-associated diarrohoea and colitis. The manifestations range from diarrhoea to life-threatening damage to the large intestine. It is noted as a nosocomial and community acquired infection in most of the countries including India.
openaire +2 more sources
Cutting edges in Clostridioides difficile infections
Swiss Medical Weekly, 2021 Clostridioides difficile is the most common cause of hospital-acquired diarrhoea and one of the most important causes of hospital-acquired infections.
Ana Durovic, Sarah Tschudin-Sutter
doaj +3 more sources
Family Medicine & Primary Care ReviewClostridioides difficile infection is the most common cause of antibiotic-associated diarrhea. IDSA/SHEA, ESCMID and ACG updated the clinical practice guidelines for CDI in 2021. This paper is an attempt to summarize these guidelines.
Mateusz Piotr Baran +4 more
doaj +2 more sources
Hospital Infection Control: Clostridioides difficile
Clinics in Colon and Rectal Surgery, 2020 Abstract Clostridioides difficile remains a leading cause of healthcare-associated infection. Efforts at C. difficile prevention have been hampered by an increasingly complex understanding of transmission patterns and a high degree of heterogeneity among existing studies. Effective prevention of C.
Turner, Nicholas A, Anderson, Deverick J
openaire +4 more sources
Changes in the Epidemiology of Clostridioides difficile Infection. [PDF]
Infect Dis Clin North AmThis article describes the epidemiology of Clostridioides difficile infection (CDI) by outlining common approaches to CDI surveillance, including the application of a case definition and risk adjustment, and summarizing recent global trends in the incidence or prevalence of CDI.
Guh AY, McDonald LC.
europepmc +4 more sources
Microbiome Therapeutics for Clostridioides difficile Infection. [PDF]
Infect Dis Clin North AmMicrobiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal microbiota transplant, fecal microbiota products, and live biotherapeutic products.
Lucky CW +4 more
europepmc +3 more sources
A Review of Therapies for Clostridioides difficile Infection
AntibioticsClostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj +3 more sources
Editorial: Clostridioides difficile infection
Frontiers in MedicineGuido Granata +2 more
doaj +3 more sources
International Journal of Infectious Diseases, 2022 Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI) have been updated. However, in addition to the clinical efficacy data, the drug of choice should ideally represent optimal antimicrobial stewardship, with an ...
Marcela Krutova, Mark Wilcox, Ed Kuijper
doaj +1 more source